Progesterone for preterm labour
- PMID: 27028883
- DOI: 10.1111/1471-0528.13976
Progesterone for preterm labour
Comment in
-
Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial.BJOG. 2016 Nov;123(12):1990-1999. doi: 10.1111/1471-0528.13956. Epub 2016 Mar 30. BJOG. 2016. PMID: 27028759
Comment on
-
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.N Engl J Med. 2003 Jun 12;348(24):2379-85. doi: 10.1056/NEJMoa035140. N Engl J Med. 2003. PMID: 12802023 Clinical Trial.
-
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.Ultrasound Obstet Gynecol. 2007 Oct;30(5):687-96. doi: 10.1002/uog.5158. Ultrasound Obstet Gynecol. 2007. PMID: 17899572 Clinical Trial.
-
Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.Lancet. 2009 Jun 13;373(9680):2034-40. doi: 10.1016/S0140-6736(09)60947-8. Lancet. 2009. PMID: 19523680 Clinical Trial.
-
Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. doi: 10.1002/uog.9017. Epub 2011 Jun 15. Ultrasound Obstet Gynecol. 2011. PMID: 21472815 Free PMC article. Clinical Trial.
-
17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.Obstet Gynecol. 2011 Sep;118(3):513-520. doi: 10.1097/AOG.0b013e31822ad6aa. Obstet Gynecol. 2011. PMID: 21860279 Clinical Trial.
-
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.Am J Obstet Gynecol. 2012 Nov;207(5):390.e1-8. doi: 10.1016/j.ajog.2012.09.013. Epub 2012 Sep 17. Am J Obstet Gynecol. 2012. PMID: 23010094 Free PMC article. Clinical Trial.
-
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.BJOG. 2015 Jan;122(1):80-91. doi: 10.1111/1471-0528.13061. Epub 2014 Sep 11. BJOG. 2015. PMID: 25209926 Clinical Trial.
-
A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.N Engl J Med. 2015 Nov 26;373(22):2141-8. doi: 10.1056/NEJMoa1504927. N Engl J Med. 2015. PMID: 26605928 Clinical Trial.
Similar articles
-
The management of preterm labour.Arch Dis Child Fetal Neonatal Ed. 2007 Mar;92(2):F88-93. doi: 10.1136/adc.2005.082289. Arch Dis Child Fetal Neonatal Ed. 2007. PMID: 17337673 Free PMC article. Review. No abstract available.
-
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.BJOG. 2015 Jan;122(1):80-91. doi: 10.1111/1471-0528.13061. Epub 2014 Sep 11. BJOG. 2015. PMID: 25209926 Clinical Trial.
-
Threatened preterm labour - analysis of the cytokine profile and progesterone treatment efficiency.J Matern Fetal Neonatal Med. 2017 Apr;30(7):814-817. doi: 10.1080/14767058.2016.1186638. Epub 2016 Jun 3. J Matern Fetal Neonatal Med. 2017. PMID: 27151935
-
[Nutri-mag--right of choice for magnesium tocolytic therapy].Akush Ginekol (Sofiia). 2009;48 Suppl 2:12-5. Akush Ginekol (Sofiia). 2009. PMID: 20380090 Bulgarian.
-
Drugs for preterm labour.Practitioner. 1993 Jul;237(1528):582-4. Practitioner. 1993. PMID: 8415391 Review. No abstract available.
Cited by
-
Progesterone inhibits contraction and increases TREK-1 potassium channel expression in late pregnant rat uterus.Oncotarget. 2017 Dec 7;9(1):651-661. doi: 10.18632/oncotarget.23084. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416642 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources